Although CD4 + and CD8 + T cells differ in the strength of their positively selecting signal, endogenous positively selecting ligands have been identified only for major histocompatibility complex (MHC) class I-restricted T cell antigen receptors (TCRs). Here we screened for ligands able to positively select MHC class II-restricted TCRs using thymocytes from four I-E k -restricted TCR-transgenic mice and a large panel of self peptides. One peptide, gp250, induced positive selection of AND CD4 + T cells, had no homology with the AND TCR agonist ligand and was recognized with a high degree of specificity. The gp250 peptide acted as a coagonist to initiate the activation and enhance the survival of peripheral AND CD4 + T cells. Thus, positively selecting ligands are critical in thymocyte development and in the activation and maintenance of peripheral T cells.
Self peptides are required during positive and negative selection in the thymus. Weak interactions between T cell antigen receptors (TCRs) on double-positive (DP) thymocytes and complexes of self peptide and major histocompatibility complex (MHC) on cortical thymic epithelial cells induce positive selection and prevent death by neglect [1] [2] [3] [4] . Positive selection ensures that TCRs are restricted by the self MHC alleles present in the thymus. MHC class I-and MHC class II-restricted T cells share many common features but do have some considerable differences. The processes of positive selection and commitment of DP thymocytes to CD4 + single-positive (CD4SP) and CD8 + single-positive (CD8SP) lineages are intricately linked. Stronger signals lead to the development of CD4SP cells, whereas weaker signals lead to CD8SP cells 3, 4 . The CD4 and CD8 coreceptors are obvious candidates to influence the positive selecting signal strength, as these coreceptors differ in their subunit composition, binding affinity for MHC molecules and signaling capacity. Alternatively and/or in combination, the interactions between TCRs and positively selecting self peptide-MHC class I versus self peptide-MHC class II complexes may differ in kinetics and/or affinity. However, the present lack of any naturally occurring self peptides identified to positively select MHC class II-restricted T cells precludes a direct comparison.
The nature of the TCR ligand(s) involved in positive selection has long been an area of intense interest, with the initial contribution of self peptides being suggested by several compelling studies 5, 6 . The self peptide or petides that positively selects (select) an individual TCR is (are) rare in the universe of self peptides, which indicates a certain degree of specificity of positively selecting ligands [7] [8] [9] [10] [11] [12] . The naturally occurring positively selecting self peptides that have been identified so far are all MHC class I restricted. Although a single peptide-MHC class II molecule can positively select a large and broadly reactive TCR repertoire [13] [14] [15] [16] [17] [18] , almost all of these T cells are negatively selected when exposed to antigen-presenting cells (APCs) expressing a normal self-peptide repertoire. These reductionist studies showed that one peptide-MHC class II species is able to positively select a substantial number of T cells but did not identify an endogenous peptide able to positively select a MHC class II-restricted TCR.
Self peptides also participate in the activation of mature T cells 19 , and can localize together with agonist peptides at the immunological synapse 20 . The localization of self peptides together with agonist peptides has functional relevance, as some self peptides augment the initiation of T cell activation induced by a small amount of agonist peptide. The pseudodimer model supports a mechanism whereby the monomeric CD4 coreceptor allows certain self peptide-MHC complexes (called 'coagonists') to contribute to T cell activation. For example, several self peptides act as coagonists and enhance the activation of 5C.C7 T cells specific for moth cytochrome c peptide bound to I-E k (MCC-I-E k ) 21, 22 . However, a relationship between positively selecting peptides and coagonists has not been established.
Thymic positively selecting self peptides have also been hypothesized to influence peripheral T cell survival. The possibility that presentation of self peptides by peripheral APCs generates sufficient tonic TCR signaling to maintain peripheral T cell survival and render T cells sensitive to foreign antigen is an appealing hypothesis 23 with little experimental support. Some evidence indicates that peptides that mediate positive selection can also facilitate the homeostatic proliferation of naive T cells [24] [25] [26] [27] [28] . For example, naive CD4 + cells from A r t i c l e s C57BL/6 (B6) mice fail to proliferate in T cell-depleted H2-DMdeficient hosts, whereas naive CD4 + cells from H2-DM-deficient mice proliferate strongly in H2-DM-deficient hosts 24, 25 . Similarly, ovalbumin-specific CD8 + T cells fail to proliferate when transferred into mice deficient in the transporter associated with antigen processing but do proliferate when transferred into mice expressing a transgene encoding a positively selecting altered peptide ligand of ovalbumin 26 . Further support of the hypothesis that positively selecting self peptides can influence the proliferation and survival of naive T cells awaits the identification of a positively selecting self peptide for MHC class II-restricted T cells.
To gain insight into the nature of self peptide(s) able to positively select MHC class II-restricted TCRs, the potential differences in signal strength that facilitate positive selection of CD4 + and CD8 + T cells, the relationship between positively selecting self peptides and coagonists, and the role of positively selecting self peptides in the survival of peripheral T cells, we sought to identify a naturally occurring self peptide able to positively select an MHC class II-restricted TCR. We tested a panel of 95 self peptides for their ability to positively select four different TCRs (AND, N3.L2, 2.102 and A1). We identified one self peptide from the endocytic receptor protein gp250 (the peptide itself is called 'gp250' here) that supported the positive selection of AND T cells. No peptides were able to positively select the other TCRs tested. The gp250 peptide has no homology with the AND TCR agonist peptide MCC, but single-amino acid substitutions of gp250 disrupted its ability to mediate positive selection; these findings indicate TCR specificity for the positively selecting self peptide. Notably, the positively selecting self peptide acted as a coagonist for peripheral AND T cells and enhanced their survival, thereby establishing a link between positive selection and the activation and survival of peripheral T cells.
RESULTS
A peptide that positively selects the AND TCR To establish a system to screen for positively selecting self peptides, we tested the ability of a large panel of I-E k -binding self peptides to induce upregulation of CD69 on DP thymocytes. We bred four I-E krestricted TCR-transgenic mouse lines onto nonselecting MHC and recombination-activating gene 1-deficient (Rag1 −/− ) backgrounds: AND.Rag1 −/− H-2 d (MCC-I-E k specific); N3L2.Rag1 −/− H-2 b (Hb-I-E k specific); 2.102.Rag1 −/− H-2 b (Hb-I-E k specific); and A1.Rag1 −/− H-2 b (HY-I-E k specific). The thymocytes from each of the TCR-transgenic mice were mainly DP with no single-positive cells, indicating the absence of positive selection (Supplementary Fig. 1) . A panel of 95 unique endogenous self peptides from the CH27 mouse B cell lymphoma line has been identified, characterized and confirmed to bind to I-E k molecules 29 . This panel represents approximately 5% of the different peptide species presented by I-E k molecules on the APC surface 30 . We loaded each peptide individually onto I-E k -immunoglobulin (I-E k -Ig) dimers and tested their ability to induce CD69 upregulation on DP thymocytes from each of the TCR-transgenic mice. One peptide, gp250, strongly stimulated CD69 upregulation on AND thymocytes ( Fig. 1) . None of the peptides for the N3L2, 2.102 or A1 TCRs stimulated CD69 expression, whereas the corresponding agonist peptide for each TCR strongly stimulated CD69 expression ( Fig. 1 and Supplementary  Fig. 2 ). Thus, gp250 was a candidate positively selecting self peptide for AND TCR-transgenic cells.
Having established that gp250 upregulated CD69 on AND thymocytes, we wanted to determine directly its ability to positively select CD4SP T cells in thymocyte reaggregate cultures. The cortical thymic epithelial cell line ANV41.2 transfected with I-E k is unable to promote positive selection because of inefficient MHC class II processing and presentation 13 . However, the addition of low concentrations of agonist peptide or altered peptide ligands to ANV41.2 cells can facilitate the positive selection of AND TCR-transgenic T cells 13 . Similarly, treatment of the ANV41.2 cells with interferon-γ (IFN-γ) restores MHC class II processing and presentation and facilitates positive selection in the absence of exogenous peptides 13 (unpublished observations). We incubated DP thymocytes from A r t i c l e s newborn AND.Rag1 −/− H-2 d mice for 4 d with ANV41.2 I-E k cells (not treated with IFN-γ) and gp250 and analyzed the cultures for the presence of CD4SP T cells (Fig. 2) . The addition of gp250 induced a substantial population of CD4SP thymocytes, whereas untreated ANV41.2 I-E k cells (data not shown) or ANV41.2 I-E k cells pulsed with control peptide did not ( Fig. 2a) . In five experiments, gp250 consistently induced a CD4SP population of AND TCR-transgenic cells, ranging from 2.8% to 7.3%. However, ten pools each containing ten of the 95 I-E k self peptides in reaggregate culture all failed to induce CD4SP differentiation of thymocytes from the three other TCR-transgenic lines (data not shown).
In addition to showing commitment to the CD4SP lineage, the CD4SP cells in gp250-treated cultures also expressed markers of positive selection, including upregulation of CD5, CD69 and TCR ( Fig. 3a,b) . Unlike DP thymocytes but like mature CD4SP T cells, the gp250-selected CD4SP T cells produced cytokines, including interleukin 2 (IL-2) and IFN-γ, in response to stimulation with phorbol 12-myristate 13-acetate and ionomycin ( Fig. 3c,d) . This finding is consistent with published results indicating that only committed CD4SP cells acquire the ability to produce IL-2 and IFN-γ 31 and suggests that gp250-selected CD4SP were both phenotypically and functionally mature.
The gp250 peptide is derived from a sortilin-related multifunctional endocytic receptor protein that is constitutively expressed in dendritic cells, macrophages, B cells, and cortical and medullary thymic epithelial cells 32 . As a membrane protein in the endocytic pathway, gp250 is readily accessible to the MHC class II-processing pathway, consistent with our identification of the gp250 peptide bound to I-E k on a B cell line. The 'anatomy' of I-E k -restricted T cell epitopes has been extensively studied structurally and functionally [33] [34] [35] [36] . There are four TCR contact residues (P2, P3, P5 and P8) and four I-E k -binding residues (P1 and P9 (the main anchors), and P4 and P6 (the secondary anchors)). We found that gp250 differed from MCC at all of the predicted TCR contact residues (Fig. 4a) . The P1 and P9 MHC anchor residues were identical in gp250 and MCC, but the two peptides differed at the P4 and P6 MHC anchor residues. Nevertheless, the reaggregate cultures established that gp250 was a true positively selecting self peptide for AND TCR-transgenic cells.
Positive selection by gp250 has specificity
In our screen of 95 self peptides and four I-E k -restricted TCRs, gp250 was the only self peptide able to positively select CD4SP thymocytes, which indicates that the process of positive selection involves a high degree of peptide specificity. To examine the degree of peptide specificity of gp250-mediated positive selection in more detail, we tested the sensitivity of positive selection to single conservative amino acid substitutions at each of the four predicted TCR contact residues of gp250. We altered P2 (Ile to Ala), P3 (Ala to Ile), P5 (Gly to Ala) and P8 (Gly to Ile; Fig. 4b) . Notably, none of the mutant peptides promoted positive selection ( Fig. 4c) , even at concentrations of up to 50 µM. We also tested the involvement of the secondary MHC anchor residues in the specificity of positive selection by introducing the MHC anchor residues of MCC peptide (at P4 and P6) into gp250. Subtle changes at the P6 anchor residue can have substantial effects on the recognition of peptides by T cells 34 . Indeed, the chimeric peptide gp250-MCC did not positively select AND T cells ( Fig. 4d) , which demonstrates an important role for the MHC anchor residues in generating a positively A r t i c l e s selecting self peptide. These findings show a high degree of specificity of positive selection of the AND TCR by gp250.
The gp250 peptide acts as a coagonist for peripheral T cells
Most peripheral T cells frequently encounter self peptide-MHC ligands but never encounter cognate foreign antigen(s). An important but unanswered question is whether positively selecting self peptides have a role in the maintenance and/or activation of peripheral T cells.
To confirm that the gp250 peptide did not directly activate peripheral AND TCR-transgenic T cells, we cultured naive AND TCR-transgenic T cells (Fig. 5a) or primary AND TCR-transgenic T cell blasts (Fig. 5b) with gp250 and CH27 cells as APCs. Even high concentrations of gp250 did not stimulate the proliferation of AND T cells.
To determine if gp250 could function as a coagonist for AND TCR-transgenic T cells, we used I-E k -Ig dimers loaded with MCC and either gp250 or the control peptide hemoglobin (Hb). Notably, the three peptides bound with identical affinity to I-E k molecules (Supplementary Fig. 3) . We loaded I-E k -Ig dimers with various ratios of MCC and gp250 or MCC and Hb (1:10 to 1:1,000) with the goal of identifying an MCC/Hb ratio that caused minimal stimulation, which permitted assessment of the coagonist activity of gp250 (Supplementary Fig. 4 ). Hb did not upregulate CD69 and did not positively select AND TCR-transgenic T cells in thymic reaggregate culture ( Figs. 2 and 3) . Ratios of 1:80 and 1:100 for the control heterodimers (MCC-Hb) resulted in minimal stimulation of AND T cells (Fig. 6a) . In contrast, heterodimers of MCC and gp250 at these ratios strongly stimulated AND TCR-transgenic T cell proliferation (Fig. 6a) , which suggests that gp250 exerts coagonist activity. The MCC/peptide ratio of 1:20 was stimulatory for both gp250 and Hb because of the existence of substantial amounts of MCC-MCC homodimers in these preparations. Conversely, the ratio of 1:1,000 was nonstimulatory for both gp250 and Hb, as these preparations were composed mostly of gp250-gp250 homodimers and contained very few MCC-MCC homodimers or MCC-gp250 heterodimers.
The initial report of coagonists demonstrated that several self peptides could act as coagonists for 5C.C7 T cells 21 , which indicated a modest degree of peptide specificity. To examine the specificity of the gp250 coagonist activity, we tested the coagonist activity of the gp250 peptides with single-amino acid substitutions. Two of the substituted gp250 peptides (P2 (Ile to Ala) and P3 (Ala to Ile)) were able to act as coagonists, whereas two were not (P5 (Gly to Ala) and P8 (Gly to Ile); Fig. 6b ). In contrast, none of the mutant peptides induced positive selection. Thus, a positively selecting self peptide can act as a coagonist for a peripheral T cell, and coagonism may require less peptide specificity than does positive selection.
Enhanced survival of peripheral T cells via gp250
Newly generated T cells egress from the thymus and seed in the periphery to form the large pool of long-lived circulating naive T cells. Self peptide-MHC complexes in general are critical for the survival and homeostatic proliferation of T cells transferred into lymphopenic hosts 37, 38 , but the nature and specificity of the self peptide-MHC ligands that mediate this effect have not been established. We tested the effect of gp250 on the homeostatic proliferation of AND TCR-transgenic cells in vivo (Fig. 7) . We injected B6.K Rag1 −/− mice with 0.5 mg gp250 or Hb on days −1 and +1 and injected the mice with AND TCR-transgenic T cells labeled with the cytosolic dye CFSE on day 0. In both the gp250-treated mice and Hb-treated mice, we observed proliferation of the AND TCRtransgenic T cells (Fig. 7a) ; however, we recovered two-to ninefold more AND TCR-transgenic CD4 + T cells from the gp250-injected mice (Fig. 7b) . We also obtained similar results with a lower peptide dose of gp250 (0.1 mg; Supplementary Fig. 5) . These findings show that the administration of additional gp250 enhanced the survival of AND TCR-transgenic T cells undergoing homeostatic proliferation. None of the gp250 peptides with mutant TCR contact residues enhanced the survival of AND TCR-transgenic CD4 + T cells (Fig. 7c) , which demonstrated a degree of specificity identical to that observed for positive selection (Fig. 4d) . Thus, the positively selecting self peptide gp250 also substantially influences peripheral T cells by enhancing their survival.
DISCUSSION
Here we have shown that the recognition of positively selecting self peptides has an unexpectedly high degree of specificity and that in the periphery, these self peptides can act as coagonists and also enhance the survival of T cells. The study of self peptides in the positive selection of CD4 + T cells has lagged behind that of CD8 + T cells because of a lack of suitable genetic models that limit the display of A r t i c l e s endogenous self peptides. Our approach was to use a library of 95 I-E k self peptides to examine the positive selection of four different I-E k -restricted transgenic TCRs specific for three different antigens, which we bred onto a Rag1 −/− nonselecting genetic background. In the initial screening, we observed an unexpected degree of specificity; only one peptide (gp250) positively selected one TCR (AND). The 379 other combinations of self peptide and TCR did not result in positive selection. Additionally, positive selection was highly specific and depended on each TCR contact residue, as single substitutions of TCR contact residues of gp250 abolished the ability of this peptide to positively select AND TCR-transgenic T cells. This specificity also extended to the MHC anchor residues, which influence the overall conformation of the peptide in the MHC binding groove. Together these results show a degree of peptide specificity during positive selection similar to that observed during the recognition of foreign peptides by peripheral T cells. Studies of the positive selection of CD8 + T cells also support the idea of peptide specificity in positive selection. A seminal study showed that altered peptide ligands of the ovalbumin peptide SIINFEKL differ in their ability to positively select OT-I T cells and that only altered peptide ligands with antagonist activity, not those with agonist activity, can promote positive selection [7] [8] [9] . Subsequent work has identified only two naturally occurring H-2K b -bound self peptides (CPα1 and β-catenin) that can promote the positive selection of OT-I CD8SP cells 10 . Those studies and our studies here used in vitro fetal thymic organ cultures or reaggregate cultures, which produce limited numbers of positively selected single-positive T cells that develop and require relatively high concentrations of peptides. It is possible that these in vitro culture models complicate our calculation of the number of peptides that were able to positively select MHC class II-restricted TCRs, but in vivo experiments manipulating the peptide repertoire without reducing it to a single species are not available. A study has reported that the genetic elimination of an immunoproteasome subunit specifically expressed in cortical thymic epithelial cells diminishes the positive selection of some but not all MHC class I-restricted TCR-transgenic cells tested 39 . These findings may indicate that the peptide(s) involved in the positive selection of these individual cells is (are) only generated in the presence of this immunoproteasome subunit, which indicates a considerable degree of specificity.
Do CD4 + and CD8 + T cells interact with endogenous peptides in an identical way or in a similar but distinct way? Our identification of an endogenous MHC class II positively selecting self peptide will now permit direct comparison of the positive selection of CD4 + and CD8 + T cells, as well as testing of the hypothesis that positive selection of CD4 + T cells requires a stronger signal through the TCR. The relative inefficiency in generating large numbers of cells in in vitro positive-selection assays makes biochemical studies difficult, but green fluorescent protein-based reporter assays or single-cell flow cytometry assays will greatly facilitate such studies. For CD8 + T cells, a pseudodimer model does not have to be evoked, given the dimeric nature of CD8 molecules; however, self peptides have also been shown to function as coagonists in MHC class I-restricted responses 40 . Thus, it remains to be determined how endogenous peptides augment the activation of CD4 + and CD8 + peripheral T cells and if there is a difference in the degree of peptide specificity of coagonists for CD4 + and CD8 + T cells. According to the pseudodimer model, CD4 monomers, unlike CD8 heterodimers, are able to crosslink two TCRs to form a pseudodimer with one TCR bound to an agonist peptide and the other bound to a self peptide 41 . The recognition requirements for coagonists have not been established, but it seems there is flexibility, given that three of seven peptides tested were active coagonists for 5C.C7 T cells 22 and our findings that two separate gp250 peptides with substitutions of TCR contact residues still retained coagonist activity, whereas these same mutants were unable to mediate positive selection.
There is mounting evidence that interactions with self peptide-MHC ligands are important for the long-term maintenance of T cells 37, 38 . Here we studied homeostatic proliferation as a surrogate assay for the effect of gp250 on the maintenance of peripheral T cells. We recovered many more AND cells from gp250-injected mice than from control peptide-injected Rag1 −/− mice, which indicated that the presence of the positively selecting self peptide enhanced the survival of peripheral T cells. The results obtained with the gp250 peptides with single substitutions indicated that the peptide specificity involved in homeostatic proliferation was similar to positive selection; the peptides with single substitutions of TCR contact residue that functioned as coagonists but not as positively selecting ligands did not enhance the homeostatic proliferation of peripheral CD4 + T cells. Overall, our findings have shown that the interaction of a T cell with a positively selecting self peptide-MHC ligand is not only a developmental process in the thymus but also a life-long interaction critical for the activation and survival of the T cell.
Our demonstration of a high degree of peptide specificity raises the key question of how many different T cells can be positively selected by one peptide-MHC species. Obviously there is not a monogamous relationship between a peptide-MHC and a single TCR. It has A r t i c l e s been estimated that an APC displays approximately 2 × 10 3 different peptide families on MHC class II molecules 30 (a peptide family includes peptides with the same core P1-P9 residues, with variable numbers of amino-and carboxy-terminal extensions) and that the mouse has a total of 3 × 10 7 different T cells. Thus, a single peptide family must select several thousand different T cells. Even if our estimate of the number of different peptide families on an APC is low and an APC expresses 2 × 10 4 different peptide families, each peptide would still have to select more than one T cell. The finding that mice expressing a single peptide-MHC complex are able to positively select substantial populations of T cells supports this conclusion [14] [15] [16] [17] [18] . There could also be a spectrum of the ability of a peptide to positively select, with some being dominant selectors; however, this would not obviate the need for a single peptide-MHC to select more than one T cell. The idea that emerges from our studies is that there is a dynamic network of selecting interactions in the thymus involving the self peptide-MHC ligands displayed on the surface of cortical thymic epithelial cells. A single DP thymocyte must scan the surface of a cortical thymic epithelial cell to find an appropriate self peptide-MHC complex that provides the strength of signal required for positive selection. However, only a few different self peptide-MHC complexes would be able to select each T cell, and most DP thymocytes would fail to be selected and die from neglect, as is known to occur.
In this issue of Nature Immunology, Ebert et al. 42 also report a high degree of peptide specificity in positive selection. Using the same set of I-E k self peptides, they identify only one peptide, group-associated antigen-polymerase (Gag-Pol), able to positively select the 5C.C7 MCC-I-E k -specific TCR. The notable finding of these two studies is that two different, mutually exclusive peptides are able to positively select two MCC-I-E k -specific TCRs. However, the Gag-Pol peptide did not positively select AND TCR-transgenic T cells and the gp250 peptide did not select 5C.C7 TCR-transgenic T cells 42 . The gp250 and Gag-Pol peptides do not have any similarities with each other or with MCC in their TCR contact residues. However, the AND and 5C.C7 TCRs are highly similar; both use variable α-chain 11 (V α 11) and V β 3 segments, and they differ by only four amino acids in the complementarity-determining region 3 α-chain 43 . Thus, these two very similar TCRs, which recognize the same antigen, are positively selected by different self peptides. These findings collectively suggest that there is not a common positively selecting self peptide for a set of closely related TCRs that recognize the same antigen and indicate that there is a unique relationship between a given TCR and a self peptide-MHC complex.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
